Case Study : Rituxan – A Brand which Pharma Industry reckon
Brand Name: Rituxan Company: Roche 2017 U.S. sales: $4.41 billion Disease: Blood cancers, rheumatoid arthritis Dosage form: Injection for Intravenous Use Rituxan (rituximab) is a... Read More
Cipla’s JV with Jiangsu Acebright Pharma in China
Cipla, a Rs. 15,900 crore plus fourth largest Indian pharma company, has entered into a joint venture agreement with Jiangsu Acebright Pharmaceutical... Read More
Case Study: Gilead and Galapagos – R&D collaboration
Posted on15 Jul 2019
Comments0
Gilead Sciences, Inc. and Galapagos NV have entered into a 10-year global research and development collaboration. Through this agreement, Gilead will gain... Read More
Gilead introduces Asia Pacific Rainbow Grants program
Gilead Sciences announced the launch of the 2019 Gilead Asia Pacific Rainbow Grants programme to support community-led programs for people living with... Read More
Case Analysis: Insight on AbbVie’s acquisition of Allergan
On June 25, 2019, AbbVie Inc. and Allergan announced that the companies have entered into a definitive transaction agreement under which AbbVie... Read More
Glenmark’s licensing deal with Novartis to distribute three respiratory drugs in Brazil
Glenmark Farmacêutica, has entered into an exclusive partnership agreement with Novartis to distribute latter’s three respiratory products in Brazil. Under the terms... Read More
Case Study: Why Pfizer acquiring Array Biopharma?
Pfizer Inc. and Array BioPharma Inc. have entered into a definitive merger agreement under which Pfizer will acquire Array, a commercial stage... Read More
Pharma Case Study : Vertical Integration – Relevium’s acquisition of Lifeline Pharma SAS
Posted on14 Jun 2019
Comments0
Relevium Technologies Inc., is pleased to announce that Biocannabix Health Corporation, a wholly-owned subsidiary of Relevium has executed on June 12, 2019... Read More
Takeda, Frazier Healthcare Partners to launch Phathom Pharma
Takeda Pharmaceutical and Frazier Healthcare Partners have announced a collaboration to launch Phathom Pharmaceuticals, a biopharmaceutical company focused on the development and... Read More
Novatis’s Xiidra acquisition from Takeda for USD 5.3 billion
Novartis has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with Xiidra (lifitegrast ophthalmic solution) 5%... Read More